Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Argenica Therapeutics Ltd ( (AU:AGN) ).
Argenica Therapeutics Limited has announced the details of its upcoming Annual General Meeting, scheduled for November 12, 2025, in Perth, Australia. Shareholders are encouraged to participate either in person or by proxy, with voting instructions required by November 10, 2025. The company has opted for electronic distribution of meeting materials, reflecting a modern approach to shareholder communication.
The most recent analyst rating on (AU:AGN) stock is a Buy with a A$0.63 price target. To see the full list of analyst forecasts on Argenica Therapeutics Ltd stock, see the AU:AGN Stock Forecast page.
More about Argenica Therapeutics Ltd
Argenica Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutic solutions for neurological conditions. The company is committed to advancing its research and development efforts to address unmet medical needs in this sector.
Average Trading Volume: 526,512
Technical Sentiment Signal: Sell
For a thorough assessment of AGN stock, go to TipRanks’ Stock Analysis page.